Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. (Q39410834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ryan T Groeschl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

T Clark Gamblin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

30 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

3591-3595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23720072%20AND%20SRC:MED&resulttype=core&format=json

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Recurrence after microwave ablation of liver malignancies: a single institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Long-term survival after radiofrequency ablation of complex unresectable liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Radio-frequency ablation of colorectal liver metastases in 167 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: a strategy in the era of organ shortage

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5

Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3031-5